Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis

International Journal of Cancer

Volumn 67, Issue 3, 1996, Pages 423-429

  Xing, Rosie Hongmei ^a   Rabbani, Shafaat Ahmed ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GROWTH REGULATION; METASTASIS POTENTIAL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

ADENOCARCINOMA; ANIMALS; CELL DIVISION; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RATS; RATS, INBRED F344; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TRANSFECTION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0029834684     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960729)67:3<423::AID-IJC18>3.0.CO;2-8     Document Type: Article

References (20)

1. ACHBAROU, A., KAISER, S., TREMBLAY, G., SAINTE-MARIE, L.G., BRODT, P., GOLTZMAN, D. and RABBANI, S.A., Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res., 54, 2372-2377 (1994).
2. CROWLEY, C.W., COHEN, R.L., LUCAS, B.K., LIU, G., SHUMAN, M.A. and LEVINSON, A.D., Prevention of metastasis by inhibition of the urokinase receptor. Proc. nat. Acad. Sci. (Wash.), 90, 5021-5025 (1993).
3. DANØ, K., BEHRENDT, M., BRÜNNER, N., ELLIS, V., PLOUGH, M. and PYKE, C., The urokinase receptor protein structure and role of plasminogen activator and cancer invasion. Fibrinolysis, 8, 189-202 (1994).
4. DUGGAN, C., MAGUIRE, T., MCDERMOTT, E., O'HIGGINS, H., FENNELLY, J.J. and DUFFY, M.J., Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int. J. Cancer, 61, 597-600 (1995).
5. GRØNDAHL-HANSEN, J., RALFKIAER, E., KIRKEBY, L.T., KRISTENSEN, P., LUND, L.R. and DANØ, K., Localization of urokinase type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Amer. J. Pathol., 138, 111-117 (1991).
6. HOLLAS, W., BLASI, F. and BOYD, D., Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res., 51, 3690-3695 (1991).
7. HOLLAS, W., SORAVIA, E., MAZAR, A.P., HENKIN, J., BLASI, F. and BOYD, D., Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell line. Biochemical J., 285, 629-634 (1992).
8. JÄNICKE, F., SCHMITT, M. and GRAEFF, H., Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer. Semin. Thrombosis Hemostasis, 17, 303-312 (1991).
9. KARIKO, K., KUO, A., BOYD, D., OKADA, S.S., CLINES, D.B. and BARNATHAN, E.S., Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Cancer Res., 53, 3109-3117 (1993).
10. KRISTENSEN, P., ERIKSEN, J., BLASI, F. and DANØ, K., Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract. J. Cell Biol., 115, 1763-1771 (1991).
11. LIU, D.F. and RABBANI, S.A., Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC-3. Prostate, 27, 269-276 (1995).
12. PLOUG, M., KJALKE, M., RØNNE, E., WEIDLE, E., HØYER-HANSEN, G. and DANØ, K., Localization of the disulfide bonds for human urokinase-type plasminogen activator receptor. A domain structure belonging to a novel superfamily of glycolipid anchored membranes proteins. J. biol. Chem., 268, 17539-17546 (1993).
13. PLOUG, M., RØNNE, E., BEHRENDT, N., JENSEN, A.L., BLASI, F. and DANØ, K., Cellular receptor for urokinase plasminogen activator. J. biol. Chem., 266, 1926-1933 (1991).
14. PYKE, C., GRAEM, N., RALFKIAER, E., RØNNE, E., HØYER-HANSEN, G., BRÜNNER, N. and DANØ, K., The receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res., 53, 1911-1915 (1993).
15. RABBANI, S.A., DESJARDINS, J., BELL, A.W., BANVILLE, D., MAZAR, A., HENKIN, J. and GOLTZMAN, D., An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem. biophys. Res. Comm., 173, 1058-1064 (1990).
16. RABBANI, S.A., HARAKIDAS, P., DAVIDSON, D.J., HENKIN, J. and MAZAR, A.P., Prevention of prostate cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA). Int. J. Cancer, 63, 840-845 (1995).
17. RABBANI, S.A., RAJWANS, N., ACHBAROU, A., MURTHY, K.K. and GOLTZMAN, D., Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts. FEBS LETT., 338, 69-74 (1994).
18. ROLDAN, A.L., CUBELLIS, M.V., MASUCCI, M.T., BEHRENDT, N., LUND, L.R., DANØ, K., APELLA, E. and BLASI, F., Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO. J., 9, 467-474 (1990).
19. RUSSO, J. and RUSSO, I.H., The etiopathogenesis of breast cancer prevention. Cancer Lett., 90, 81-89 (1995).
20. STETLER-STEVENSON, W.G., LIOTTA, L.A. and KLEINER, D.E., Extracellular matrix 6: role of matrix metalloproteases in tumor invasion and metastasis. FASEB J., 7, 1434-1441 (1993).